{
  "cik": 1806310,
  "cik_padded": "0001806310",
  "entityName": "Taysha Gene Therapies, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-115202",
      "filed": "2026-03-19",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 738000.0,
        "cash": 319767000.0,
        "eps_diluted": -0.34,
        "free_cash_flow": -93828000.0,
        "net_income": -108995000.0,
        "operating_cash_flow": -93090000.0,
        "operating_income": -110498000.0,
        "revenue": 9773000.0,
        "stockholders_equity": 246938000.0,
        "total_assets": 343320000.0,
        "total_liabilities": 96382000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.3903084984894994,
        "revenue_growth_yoy": 0.17280691227649106,
        "roa_avg2y": -0.43279119447907816,
        "roa_period_end": -0.31747349411627634,
        "roe_avg2y": -0.6845065203807036,
        "roe_period_end": -0.4413860969150151
      }
    },
    {
      "accn": "0001193125-26-115202",
      "filed": "2026-03-19",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 374000.0,
        "cash": 139036000.0,
        "eps_diluted": -0.36,
        "free_cash_flow": -81599000.0,
        "net_income": -89298000.0,
        "operating_cash_flow": -81225000.0,
        "operating_income": -91459000.0,
        "revenue": 8333000.0,
        "stockholders_equity": 71525000.0,
        "total_assets": 160364000.0,
        "total_liabilities": 88839000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 1.242069206571129,
        "revenue_growth_yoy": -0.46068215649472527,
        "roa_avg2y": -0.5361713625242048,
        "roa_period_end": -0.5568456760869023,
        "roe_avg2y": -1.2194016195327115,
        "roe_period_end": -1.248486543166725
      }
    },
    {
      "accn": "0001193125-26-115202",
      "filed": "2026-03-19",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 3869000.0,
        "cash": 143940000.0,
        "eps_diluted": -0.96,
        "free_cash_flow": -76887000.0,
        "net_income": -111566000.0,
        "operating_cash_flow": -73018000.0,
        "operating_income": -72439000.0,
        "revenue": 15451000.0,
        "stockholders_equity": 74937000.0,
        "total_assets": 172731000.0,
        "total_liabilities": 97794000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 1.3050162136194403,
        "revenue_growth_yoy": 5.175459632294165,
        "roa_avg2y": -0.7462433989839703,
        "roa_period_end": -0.6458944833295702,
        "roe_avg2y": -2.940357905278971,
        "roe_period_end": -1.4887972563620107
      }
    },
    {
      "accn": "0000950170-25-027348",
      "filed": "2025-02-26",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 20619000.0,
        "cash": 87880000.0,
        "eps_diluted": -3.78,
        "free_cash_flow": -109009000.0,
        "net_income": -166014000.0,
        "operating_cash_flow": -88390000.0,
        "operating_income": -162447000.0,
        "revenue": 2502000.0,
        "stockholders_equity": 949000.0,
        "total_assets": 126276000.0,
        "total_liabilities": 125327000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_avg2y": -0.9758870417832538,
        "roa_period_end": -1.3146916278627767,
        "roe_avg2y": -3.4467051447078854
      }
    },
    {
      "accn": "0000950170-24-033484",
      "filed": "2024-03-19",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 15304000.0,
        "cash": 149103000.0,
        "eps_diluted": -4.64,
        "free_cash_flow": -132346000.0,
        "net_income": -174523000.0,
        "operating_cash_flow": -117042000.0,
        "operating_income": -173267000.0,
        "stockholders_equity": 95383000.0,
        "total_assets": 213956000.0,
        "total_liabilities": 118573000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 1.2431250851828943,
        "roa_avg2y": -0.738195192000626,
        "roa_period_end": -0.815695750528146,
        "roe_avg2y": -1.0068102167673825,
        "roe_period_end": -1.8297075998867722
      }
    },
    {
      "accn": "0001564590-22-012782",
      "filed": "2023-03-28",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 82000.0,
        "cash": 251253000.0,
        "free_cash_flow": -30811000.0,
        "net_income": -60011000.0,
        "operating_cash_flow": -30729000.0,
        "operating_income": -43002000.0,
        "stockholders_equity": 251302000.0,
        "total_assets": 258881000.0,
        "total_liabilities": 7579000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.030158932280682206,
        "roa_avg2y": -0.4635915580001236,
        "roa_period_end": -0.2318092096368602,
        "roe_avg2y": -0.4778573618349544,
        "roe_period_end": -0.2388003278923367
      }
    },
    {
      "accn": "0001564590-22-012782",
      "filed": "2022-03-31",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -135000.0,
        "total_assets": 15000.0,
        "total_liabilities": 150000.0
      },
      "period_end": "2019-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-115202",
    "filed": "2026-03-19",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001806310.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001806310.json"
  },
  "ticker": "TSHA"
}